ReoPro retavase reperfusion of stroke safety study-imaging evaluation with computed tomography (ROSIE-CT).
Phase of Trial: Phase II
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Abciximab (Primary) ; Reteplase (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- Acronyms ROSIE-CT
- 01 Sep 2009 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.
- 01 Oct 2008 Status changed from active, no longer recruiting to completed.
- 24 Jul 2007 Status changed from recruiting to in progress.